Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 473

1.

Pulse Wave Velocity in Chronic Obstructive Pulmonary Disease and the Impact of Inhaled Therapy (SUMMIT): A Randomized Double-blind Clinical Trial.

Crim C, Anderson JA, Calverley PMA, Celli BR, Cowans NJ, Martinez FJ, Newby DE, Vestbo J, Yates JC, Brook RD.

Am J Respir Crit Care Med. 2020 Feb 4. doi: 10.1164/rccm.201908-1639LE. [Epub ahead of print] No abstract available.

PMID:
32017597
2.

Device use errors with soft mist inhalers: A global systematic literature review and meta-analysis.

Navaie M, Dembek C, Cho-Reyes S, Yeh K, Celli BR.

Chron Respir Dis. 2020 Jan-Dec;17:1479973119901234. doi: 10.1177/1479973119901234.

3.
4.

Update on Clinical Aspects of COPD. Reply.

Celli BR, Wedzicha JA.

N Engl J Med. 2019 Dec 19;381(25):2485-2486. doi: 10.1056/NEJMc1914600. No abstract available.

PMID:
31851820
5.

The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries.

Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, Vogelmeier CF, Chen R, Mortimer K, Montes de Oca M, Aisanov Z, Obaseki D, Decker R, Agusti A.

Int J Tuberc Lung Dis. 2019 Nov 1;23(11):1131-1141. doi: 10.5588/ijtld.19.0397.

PMID:
31718748
6.

The most beautiful COPD chart in the world: all together to end COPD!

Soriano JB, Ancochea J, Celli BR.

Eur Respir J. 2019 Dec 19;54(6). pii: 1902047. doi: 10.1183/13993003.02047-2019. Print 2019 Dec. No abstract available.

PMID:
31699834
7.

Plasma metabolomics and clinical predictors of survival differences in COPD patients.

Pinto-Plata V, Casanova C, Divo M, Tesfaigzi Y, Calhoun V, Sui J, Polverino F, Priolo C, Petersen H, de Torres JP, Marin JM, Owen CA, Baz R, Cordova E, Celli B.

Respir Res. 2019 Oct 15;20(1):219. doi: 10.1186/s12931-019-1167-y.

8.

Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies.

Criner GJ, Celli BR, Singh D, Agusti A, Papi A, Jison M, Makulova N, Shih VH, Brooks L, Barker P, Martin UJ, Newbold P.

Lancet Respir Med. 2020 Feb;8(2):158-170. doi: 10.1016/S2213-2600(19)30338-8. Epub 2019 Sep 28.

PMID:
31575508
9.

Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease.

Celli BR, Wedzicha JA.

N Engl J Med. 2019 Sep 26;381(13):1257-1266. doi: 10.1056/NEJMra1900500. Review. No abstract available.

PMID:
31553837
10.

Exacerbations, Health Resource Utilization, and Costs Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease Treated with Nebulized Arformoterol Following a Respiratory Event.

Navaie M, Celli BR, Xu Z, Cho-Reyes S, Dembek C, Gilmer TP.

Chronic Obstr Pulm Dis. 2019 Oct 23;6(4). doi: 10.15326/jcopdf.6.4.2019.0127.

11.

Inhalation Technique Errors with Metered-Dose Inhalers Among Patients with Obstructive Lung Diseases: A Systematic Review and Meta-Analysis of U.S. Studies.

Cho-Reyes S, Celli BR, Dembek C, Yeh K, Navaie M.

Chronic Obstr Pulm Dis. 2019 Jul 24;6(3):267-280. doi: 10.15326/jcopdf.6.3.2018.0168. Review.

12.

It is time for the world to take COPD seriously: a statement from the GOLD board of directors.

Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, Vogelmeier CF, Chen R, Mortimer K, Montes de Oca M, Aisanov Z, Obaseki D, Decker R, Agusti A.

Eur Respir J. 2019 Jul 4;54(1). pii: 1900914. doi: 10.1183/13993003.00914-2019. Print 2019 Jul. No abstract available.

PMID:
31273036
13.

Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial.

Celli BR, Anderson JA, Brook R, Calverley P, Cowans NJ, Crim C, Dixon I, Kim V, Martinez FJ, Morris A, Newby DE, Yates J, Vestbo J.

BMJ Open Respir Res. 2019 May 4;6(1):e000431. doi: 10.1136/bmjresp-2019-000431. eCollection 2019.

14.

Predictors of Nebulized Arformoterol Treatment: A Retrospective Analysis of Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease.

Gilmer TP, Celli BR, Xu Z, Cho-Reyes S, Dembek C, Navaie M.

COPD. 2019 Apr;16(2):140-151. doi: 10.1080/15412555.2019.1618256. Epub 2019 Jun 19.

PMID:
31215259
15.

Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment.

Celli BR, Navaie M, Xu Z, Cho-Reyes S, Dembek C, Gilmer TP.

Int J Chron Obstruct Pulmon Dis. 2019 May 15;14:1019-1031. doi: 10.2147/COPD.S199251. eCollection 2019.

16.

It's more than low BMI: prevalence of cachexia and associated mortality in COPD.

McDonald MN, Wouters EFM, Rutten E, Casaburi R, Rennard SI, Lomas DA, Bamman M, Celli B, Agusti A, Tal-Singer R, Hersh CP, Dransfield M, Silverman EK.

Respir Res. 2019 May 22;20(1):100. doi: 10.1186/s12931-019-1073-3.

17.

Benralizumab for the Prevention of COPD Exacerbations.

Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramírez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, O'Quinn S, Makulova N, Newbold P, Goldman M, Martin UJ; GALATHEA Study Investigators; TERRANOVA Study Investigators.

N Engl J Med. 2019 Sep 12;381(11):1023-1034. doi: 10.1056/NEJMoa1905248. Epub 2019 May 20.

PMID:
31112385
18.

Enriched Systemic Biomarkers in Symptomatic Unobstructed Smokers: Moving Forward?

Rodriguez-Roisin R, Celli BR.

Chest. 2019 May;155(5):886-887. doi: 10.1016/j.chest.2019.02.314. No abstract available.

PMID:
31060699
19.

Regional differences in rate of FEV1 decline in COPD: lessons from SUMMIT.

Celli BR, Anderson JA, Brook RD, Calverley PMA, Cowans NJ, Crim C, Martinez F, Newby DE, Yates J, Vestbo J.

Eur Respir J. 2019 Jun 27;53(6). pii: 1900278. doi: 10.1183/13993003.00278-2019. Print 2019 Jun. No abstract available.

PMID:
30923182
20.

Reply to Pouwels et al.: Confounding Factors Affecting sRAGE as a Biomarker for Chronic Obstructive Pulmonary Disease.

Stockley RA, Halpin D, Celli BR, Singh D.

Am J Respir Crit Care Med. 2019 Jul 1;200(1):114-115. doi: 10.1164/rccm.201903-0573LE. No abstract available.

21.

External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study.

Almagro P, Martínez-Camblor P, Miravitlles M, Rodríguez-Carballeira M, Navarro A, Lamprecht B, Ramirez-Garcia Luna AS, Kaiser B, Alfageme I, Casanova C, Esteban C, Soler-Cataluña JJ, de-Torres JP, Celli BR, Marin JM, Ter Riet G, Sobradillo P, Lange P, Garcia-Aymerich J, Anto JM, Turner AM, Han MK, Langhammer A, Sternberg A, Leivseth L, Bakke P, Johannessen A, Oga T, Cosío B, Ancochea J, Echazarreta A, Roche N, Burgel PR, Sin DD, Puhan MA, Soriano JB; 3CIA collaboration.

COPD. 2019 Feb;16(1):8-17. doi: 10.1080/15412555.2018.1484440. Epub 2019 Mar 14.

PMID:
30870059
22.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.

Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin DMG, Han M, López Varela MV, Martinez F, Montes de Oca M, Papi A, Pavord ID, Roche N, Sin DD, Stockley R, Vestbo J, Wedzicha JA, Vogelmeier C.

Eur Respir J. 2019 May 18;53(5). pii: 1900164. doi: 10.1183/13993003.00164-2019. Print 2019 May. Review.

PMID:
30846476
23.

Impact of pre-enrolment medication use on clinical outcomes in SUMMIT.

Vestbo J, Dransfield M, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Martinez F, Newby DE, Yates J, Lange P.

ERJ Open Res. 2019 Feb 25;5(1). pii: 00203-2018. doi: 10.1183/23120541.00203-2018. eCollection 2019 Feb.

24.

Patient Preferences for Endobronchial Valve Treatment of Severe Emphysema.

Mansfield C, Sutphin J, Shriner K, Criner GJ, Celli BR.

Chronic Obstr Pulm Dis. 2018 Dec 11;6(1):51-63. doi: 10.15326/jcopdf.6.1.2018.0147.

25.

Prognostic Validation Using GesEPOC 2017 Severity Criteria.

Cabrera López C, Casanova Macario C, Marín Trigo JM, de-Torres JP, Torres RS, González JM, Polverino F, Divo M, Pinto Plata V, Zulueta J, Callejas FJ, Celli B.

Arch Bronconeumol. 2019 Aug;55(8):409-413. doi: 10.1016/j.arbres.2018.12.002. Epub 2019 Feb 2. English, Spanish.

26.

The Prevalence of Obstructive Lung Disease in a Lung Cancer Screening Cohort: Analysis of the National Lung Screening Trial-American College of Radiology Image Network Cohort.

de-Torres JP, Wisnivesky JP, Bastarrika G, Wilson DO, Celli BR, Zulueta JJ.

Ann Am Thorac Soc. 2019 May;16(5):641-644. doi: 10.1513/AnnalsATS.201811-817RL. No abstract available.

PMID:
30673510
27.

Using the Peripheral Blood Eosinophil Count to Manage Patients with Chronic Obstructive Pulmonary Disease.

Celli BR, Criner GJ.

Ann Am Thorac Soc. 2019 Mar;16(3):301-303. doi: 10.1513/AnnalsATS.201810-729PS. No abstract available.

PMID:
30620613
28.

Chronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation.

Stockley RA, Halpin DMG, Celli BR, Singh D.

Am J Respir Crit Care Med. 2019 May 15;199(10):1195-1204. doi: 10.1164/rccm.201810-1860SO. Review.

PMID:
30592902
29.

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal.

Vanfleteren L, Fabbri LM, Papi A, Petruzzelli S, Celli B.

Int J Chron Obstruct Pulmon Dis. 2018 Dec 12;13:3971-3981. doi: 10.2147/COPD.S185975. eCollection 2018. Review.

30.

Network Analysis of Autopsy Diagnoses: Insights into the "Cause of Death" from Unbiased Disease Clustering.

Celli R, Divo M, Colunga M, Celli B, Mitchell-Richards KA.

J Pathol Inform. 2018 Oct 9;9:35. doi: 10.4103/jpi.jpi_20_18. eCollection 2018.

31.

Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee.

Criner GJ, Martinez FJ, Aaron S, Agusti A, Anzueto A, Bafadhel M, Barnes PJ, Bourbeau J, Chen R, Ewig J, Fabbri LM, Frith P, Halpin DMG, Han M, Montes de Oca M, Nishimura M, O'Donnell D, Papi A, Pavord I, Roche N, Rodriguez-Roisin R, Salvi S, Singh D, Sin DD, Stockley R, López Varela MV, Vestbo J, Vogelmeier CF, Washko G, Wedzicha JA, Celli BR.

Ann Am Thorac Soc. 2019 Jan;16(1):29-39. doi: 10.1513/AnnalsATS.201808-557PS. No abstract available.

PMID:
30427736
32.

Failure of Low-Dose Theophylline to Prevent Exacerbations in Patients With COPD.

Criner GJ, Celli BR.

JAMA. 2018 Oct 16;320(15):1541-1542. doi: 10.1001/jama.2018.14295. No abstract available.

PMID:
30326108
33.

Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial.

Tashkin DP, Miravitlles M, Celli BR, Metzdorf N, Mueller A, Halpin DMG, Anzueto A.

Respir Res. 2018 Oct 5;19(1):196. doi: 10.1186/s12931-018-0874-0.

34.

Inhaled corticosteroids in COPD: friend or foe?

Agusti A, Fabbri LM, Singh D, Vestbo J, Celli B, Franssen FME, Rabe KF, Papi A.

Eur Respir J. 2018 Dec 13;52(6). pii: 1801219. doi: 10.1183/13993003.01219-2018. Print 2018 Dec. Review.

PMID:
30190269
35.

Supplementation with Qter® and Creatine improves functional performance in COPD patients on long term oxygen therapy.

De Benedetto F, Pastorelli R, Ferrario M, de Blasio F, Marinari S, Brunelli L, Wouters EFM, Polverino F, Celli BR; Interdisciplinary Association for Research in Lung Disease (AIMAR) Study Group.

Respir Med. 2018 Sep;142:86-93. doi: 10.1016/j.rmed.2018.08.002. Epub 2018 Aug 7.

PMID:
30170808
36.

Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease.

Adamson PD, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Dixon IJ, Martinez FJ, Newby DE, Vestbo J, Yates JC, Mills NL.

J Am Coll Cardiol. 2018 Sep 4;72(10):1126-1137. doi: 10.1016/j.jacc.2018.06.051. Erratum in: J Am Coll Cardiol. 2018 Oct 30;72(18):2282.

37.

The Course of Lung Function in Middle-aged Heavy Smokers: Incidence and Time to Early Onset of Chronic Obstructive Pulmonary Disease.

Petersen H, Sood A, Polverino F, Owen CA, Pinto-Plata V, Celli BR, Tesfaigzi Y.

Am J Respir Crit Care Med. 2018 Dec 1;198(11):1449-1451. doi: 10.1164/rccm.201805-0861LE. No abstract available.

38.

Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial.

Byrd JB, Newby DE, Anderson JA, Calverley PMA, Celli BR, Cowans NJ, Crim C, Martinez FJ, Vestbo J, Yates J, Brook RD; SUMMIT Investigators.

Eur Heart J. 2018 Sep 1;39(33):3128-3134. doi: 10.1093/eurheartj/ehy451.

PMID:
30101300
39.

The effect of emphysema on readmission and survival among smokers with heart failure.

Kohli P, Staziaki PV, Janjua SA, Addison DA, Hallett TR, Hennessy O, Takx RAP, Lu MT, Fintelmann FJ, Semigran M, Harris RS, Celli BR, Hoffmann U, Neilan TG.

PLoS One. 2018 Jul 30;13(7):e0201376. doi: 10.1371/journal.pone.0201376. eCollection 2018.

40.

Prevalence of paradoxical bronchoconstriction after inhaled albuterol.

Schissler AJ, Celli BR.

Respir Med. 2018 Aug;141:100-102. doi: 10.1016/j.rmed.2018.06.028. Epub 2018 Jun 30.

PMID:
30053954
41.

Precision medicine in COPD exacerbations.

Agusti A, Faner R, Celli B, Rodriguez-Roisin R.

Lancet Respir Med. 2018 Sep;6(9):657-659. doi: 10.1016/S2213-2600(18)30296-0. Epub 2018 Jul 18. No abstract available.

PMID:
30029970
42.

Pharmacological Therapy of COPD: Reasons for Optimism.

Celli BR.

Chest. 2018 Dec;154(6):1404-1415. doi: 10.1016/j.chest.2018.07.005. Epub 2018 Jul 17. Review.

PMID:
30028967
43.

Improving Our Aim: Targeting Therapy with Roflumilast in Patients with Severe and Very Severe Chronic Obstructive Pulmonary Disease.

Celli BR.

Am J Respir Crit Care Med. 2018 Nov 15;198(10):1242-1244. doi: 10.1164/rccm.201806-1051ED. No abstract available.

PMID:
29953246
44.

Targeting dyspnoea in patients with very severe COPD: Practical precision medicine.

Celli BR.

Respirology. 2018 Dec;23(12):1086-1087. doi: 10.1111/resp.13359. Epub 2018 Jun 25. No abstract available.

45.

The Challenge of Controlling the COPD Epidemic: Unmet Needs.

Polverino F, Celli B.

Am J Med. 2018 Sep;131(9S):1-6. doi: 10.1016/j.amjmed.2018.05.001. Epub 2018 May 17. Review.

PMID:
29778456
46.

A Disintegrin and Metalloproteinase Domain-8: A Novel Protective Proteinase in Chronic Obstructive Pulmonary Disease.

Polverino F, Rojas-Quintero J, Wang X, Petersen H, Zhang L, Gai X, Higham A, Zhang D, Gupta K, Rout A, Yambayev I, Pinto-Plata V, Sholl LM, Cunoosamy D, Celli BR, Goldring J, Singh D, Tesfaigzi Y, Wedzicha J, Olsson H, Owen CA.

Am J Respir Crit Care Med. 2018 Nov 15;198(10):1254-1267. doi: 10.1164/rccm.201707-1331OC.

47.

Pulmonary Vascular Involvement in Chronic Obstructive Pulmonary Disease. Is There a Pulmonary Vascular Phenotype?

Kovacs G, Agusti A, Barberà JA, Celli B, Criner G, Humbert M, Sin DD, Voelkel N, Olschewski H.

Am J Respir Crit Care Med. 2018 Oct 15;198(8):1000-1011. doi: 10.1164/rccm.201801-0095PP. Review. No abstract available.

PMID:
29746142
48.

Shorter telomeres in non-smoking patients with airflow limitation.

Córdoba-Lanús E, Cabrera-López C, Cazorla-Rivero S, Rodríguez-Pérez MC, Aguirre-Jaime A, Celli B, Casanova C.

Respir Med. 2018 May;138:123-128. doi: 10.1016/j.rmed.2018.04.002. Epub 2018 Apr 3.

PMID:
29724383
49.

COPD: time to improve its taxonomy?

Celli BR, Agustí A.

ERJ Open Res. 2018 Feb 16;4(1). pii: 00132-2017. doi: 10.1183/23120541.00132-2017. eCollection 2018 Jan.

50.

Pulmonary arterial enlargement predicts long-term survival in COPD patients.

de-Torres JP, Ezponda A, Alcaide AB, Campo A, Berto J, Gonzalez J, Zulueta JJ, Casanova C, Rodriguez-Delgado LE, Celli BR, Bastarrika G.

PLoS One. 2018 Apr 25;13(4):e0195640. doi: 10.1371/journal.pone.0195640. eCollection 2018.

Supplemental Content

Support Center